Exploring how heart cells can regenerate after injury
Understanding the molecular mechanism of cardiomyocyte dedifferentiation and proliferation during regeneration
This study is looking at how heart cells can heal and grow back after injury, using zebrafish as a model because they can naturally replace damaged heart tissue, and the goal is to find ways to help human hearts recover better after problems like heart attacks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10993122 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the ability of heart cells, known as cardiomyocytes, to dedifferentiate and proliferate after injury, particularly in the context of heart disease. By studying the regenerative capabilities of the adult zebrafish heart, which can effectively replace damaged heart tissue, the research aims to uncover the biological factors that enable this process. The findings could lead to new strategies for enhancing heart repair in humans following events like heart attacks. The approach includes both molecular analysis and comparative studies between zebrafish and mammalian hearts.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of heart disease or cardiac injury, particularly those who have experienced myocardial infarctions.
Not a fit: Patients with non-cardiac related health issues or those who do not have any history of heart disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that improve heart regeneration and repair in patients with heart disease.
How similar studies have performed: Previous studies have shown promising results in understanding heart regeneration in zebrafish, indicating that this approach has potential for success in translating findings to human applications.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Tsang, Michael Waikok — University of Pittsburgh at Pittsburgh
- Study coordinator: Tsang, Michael Waikok
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.